HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Colipa president

This article was originally published in The Rose Sheet

Executive Summary

Francoise Montenay, president of Chanel S.A.S. and Bourjois S.A.S, succeeds Enrique Puig as president of the European Cosmetic, Toiletry and Perfumery Association, trade group announces. Puig served in the role for three years. In addition, cosmetic industry associations from Norway, Switzerland, the Czech Republic, Hungary, Latvia, Lithuania, the Slovak Republic and Slovenia recently joined Colipa as full members. Poland and Estonia likely will join as full members later this year, Colipa adds...

You may also be interested in...



Colipa president

Chanel S.A.S. President Francoise Montenay was re-elected president of the European Cosmetic, Toiletry and Perfumery Association during Colipa's General Assembly in early June, association announces. Montenay was elected to the post in 2004, succeeding Enrique Puig (1"The Rose Sheet" Aug. 2, 2004, In Brief). Separately, Colipa reported growth for the European cosmetics industry in 2005, noting the industry had annual turnover of €65 bil., representing "moderate" growth over 2004. Skin care, toiletries and hair care products continue to be major product categories, according to the association. Germany, France, the UK, Italy and Spain continue to be the largest markets in Europe, association notes...

Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa

The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.

Partisan Politics Returns To US FDA Congressional Oversight

The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS012334

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel